Early aging and diabetes risk with fatty liver
Part of Hormones & metabolism clinical trials.
This study looks at how early biological aging might increase the chance of developing type 2 diabetes in people with a fatty liver (a condition called MASLD). It uses routine health check-up data to understand the link.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least one abdominal ultrasound that showed fatty liver
- You have annual health records that include body mass index, waist size, blood pressure, triglycerides, HDL cholesterol, or blood sugar
- You are between 20 and 90 years old
- You do not have hepatitis B, alcoholic liver disease, or other causes of fatty liver besides MASLD
- You do not already have type 2 diabetes
- Your health records include specific blood tests like blood pressure, albumin, and fasting glucose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both type 2 diabetes and fatty liver disease to see how these conditions affect heart health over time. By participating, you'll help researchers learn more about lowering your risk of heart problems.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
This study aims to build a tool to predict how MASLD-related cirrhosis (fatty liver disease leading to liver scarring) will progress. It may help doctors and patients better understand the outlook and plan care.
This study tests a new screening tool to find advanced liver scarring in people with liver disease linked to diabetes. It helps doctors decide who needs more tests or specialist care.
This research study looks at people with type 2 diabetes to learn more about fatty liver disease. By joining, you may help doctors better understand how these conditions are linked and improve future care.
This study is looking for people with type 2 diabetes and fatty liver disease to find better ways to track how the disease progresses. They will use special tests (biomarkers) to see if the liver is getting worse over time.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.